India’s API Build-Up Plan To Bridle The Dragon

An Indian expert committee has recommended a raft of measures to revive and promote the production of active pharmaceutical ingredients (APIs) in the country, including the "judicious and liberal" use of anti-dumping duties and safeguards, with an eye on the country's huge reliance on Chinese imports.